MAPK3 and depressive symptom measurement: Model group significantly decreased compared to Normal group (P < 0.05); EA treatment increased the ratio between p-ERK1/2 and ERK compared to sham control (P < 0.01), suggesting that EA may reverse the deficits in p-ERK in the HP on depression rats.